AbbVie Inc

Healthcare · Drug Manufacturers - General

264.40$ -0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

AbbVie Inc (ABBV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 16,990 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ABBV
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	6,432	6,796	6,538	6,944	6,995	7,739	7,934	8,278	8,236	8,305	7,828	8,255	8,479	8,704	8,619	10,425	12,902	13,858	13,010	13,959	14,342	14,886	13,538	14,583	14,812	15,121	12,225	13,865	13,927	14,301	12,310	14,462	14,460	15,102	13,343	15,423	15,776	16,618	15,002	16,990	64,386
Cost of Revenue	1,504	1,555	1,616	1,528	1,616	2,280	1,927	1,934	1,835	2,022	1,694	1,819	1,920	2,006	1,942	3,711	5,050	4,684	4,213	4,523	4,390	4,320	4,052	4,170	5,022	4,170	3,986	4,240	6,485	5,704	4,094	4,202	4,212	4,396	4,002	4,346	5,304	4,552	4,218	4,291	18,365
Gross Profit	4,928	5,241	4,922	5,416	5,379	5,459	6,007	6,344	6,401	6,283	6,134	6,436	6,559	6,698	6,677	6,714	7,852	9,174	8,797	9,436	9,952	10,566	9,486	10,413	9,790	10,951	8,239	9,625	7,442	8,597	8,216	10,260	10,248	10,706	9,341	11,077	10,472	12,066	10,784	12,699	46,021
Research & Development	1,186	1,230	1,142	1,244	1,228	1,714	1,313	1,322	1,323	6,795	1,444	1,382	2,285	1,681	1,379	2,435	1,751	2,190	1,852	1,899	2,063	2,232	1,642	1,878	1,654	2,033	2,292	1,733	1,723	2,209	1,939	1,948	2,130	6,774	2,067	2,131	2,319	2,579	2,472	2,344	9,714
Selling, General & Administrative	1,381	889	1,368	1,504	1,452	727	1,791	1,760	1,919	504	1,680	1,654	1,657	780	1,695	3,527	2,846	1,431	2,842	3,164	3,083	1,160	3,127	5,412	3,304	1,417	3,039	3,268	3,372	1,355	3,315	3,377	4,205	779	3,293	3,253	3,569	3,895	3,578	3,632	14,674
Total Operating Expenses	2,567	2,883	2,515	2,753	2,685	3,665	3,104	3,582	3,242	8,724	3,124	3,036	3,942	2,742	3,074	5,962	4,597	5,421	4,694	4,995	5,646	5,492	4,769	7,118	5,187	5,449	5,471	5,112	5,161	5,402	5,418	6,262	6,417	12,196	5,608	6,183	8,568	6,257	6,050	6,267	27,142
Operating Income	2,361	2,358	2,407	2,662	2,694	1,794	2,903	2,762	3,159	-2,441	3,010	3,400	2,617	3,956	3,603	752	3,255	3,753	4,103	4,441	4,306	5,074	4,717	3,295	4,603	5,502	2,768	4,513	2,281	3,195	2,798	3,998	3,831	-1,490	3,733	4,894	1,904	5,809	4,734	6,432	18,879
Interest Expense	271	316	273	284	293	299	309	320	339	380	387	358	480	559	563	632	630	629	632	615	596	580	548	556	560	566	553	552	555	564	660	726	720	702	700	740	739	714	717	746	2,916
Pre-Tax Income	2,014	1,998	2,086	2,353	2,095	1,193	2,797	2,012	2,761	-2,373	2,544	807	2,001	3,074	3,098	-693	2,500	-1,507	3,867	1,163	3,688	4,271	4,929	1,183	4,400	2,965	475	2,610	1,953	1,212	1,755	2,146	2,084	-2,269	1,661	1,554	714	2,668	1,039	4,278	8,699
Income Tax Expense	416	607	375	438	464	1,141	14	29	14	-547	88	66	117	273	88	46	187	-1,545	312	394	508	226	436	255	448	493	234	583	172	388	383	773	520	-2,246	372	613	526	853	342	662	2,383
Net Income	1,598	1,391	1,711	1,915	1,631	52	2,783	1,983	2,747	-1,826	2,456	741	1,884	2,801	3,010	-738	2,308	36	3,553	766	3,179	4,044	4,490	924	3,949	2,473	239	2,024	1,778	822	1,369	1,370	1,561	-22	1,286	938	186	1,816	699	3,613	6,314
EBITDA	2,589	2,642	2,733	3,016	2,767	1,861	3,551	2,775	3,535	-1,551	3,434	1,667	2,984	4,142	4,220	1,494	5,422	1,187	6,714	3,978	6,411	6,830	7,530	3,791	7,165	5,688	3,155	5,422	4,743	3,852	4,489	5,003	4,883	535	4,400	4,344	3,516	5,369	3,692	8,659	21,236

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings